NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
Worsening Lipoproteins on a Low-Carb Diet
An exciting new approach to treating obesity and insulin resistance involves significant carbohydrate restriction with the goal of achieving a ketogenic state that results in…
An Evidence-Based Approach to Sitosterolemia
Sitosterolemia is a rare, autosomal, recessively inherited sterol storage disease caused by homozygous or compound heterozygous gene mutations of adenosine triphosphate-binding cassette (ABC) genes G5…
Lysosomal Acid Lipase Deficiency (LAL-D)
When treating our lipid patients it is important to always consider unusual causes of dyslipidemia in our differential diagnosis. Although rare, lysosomal acid lipase deficiency…
Dyslipidemia & Antipsychotic Medications: Who is Monitoring the Lipids?
The use of second- generation, or atypical, antipsychotics is associated with significant adverse metabolic effects. These include weight gain, glucose intolerance, and dyslipidemia.
Tuberous and Tendon Xanthomas: Don’t Overlook Sitosterolemia or Cerebrotendinous Xanthomatosis
Some inherited lipid disorders can be recognized by the deposition of cholesterol and other lipids in lesions on the body termed xanthomas. Lipid deposition can…
Dyslipidemia in the Patient Living with HIV
The development and use of antiretroviral medications to treat patients infected with HIV have dramatically changed the course of this disease from one that was…
Statins in Chronic Kidney Disease and Dialysis: Clinical Trials, Mechanisms, Dosing, and Treatment Recommendations
Patients with chronic kidney disease (CKD) including those undergoing dialysis have an increased risk of premature cardiovascular disease (CVD). CKD patients also have a high…
Apo A1 Remnant Ratio
Although low-density lipoprotein cholesterol (LDL-C) lowering with statin therapy has been part of the National Cholesterol Education Program guidelines for 26 years, significant residual cardiovascular…